• 제목/요약/키워드: Drug Screening

검색결과 533건 처리시간 0.032초

Economic Burden of Chronic Obstructive Pulmonary Disease: A Systematic Review

  • Hai Quang Pham;Kiet Huy Tuan Pham;Giang Hai Ha;Tin Trung Pham;Hien Thi Nguyen;Trang Huyen Thi Nguyen;Jin-Kyoung Oh
    • Tuberculosis and Respiratory Diseases
    • /
    • 제87권3호
    • /
    • pp.234-251
    • /
    • 2024
  • Globally, providing evidence on the economic burden of chronic obstructive pulmonary disease (COPD) is becoming essential as it assists the health authorities to efficiently allocate resources. This study aimed to summarize the literature on economic burden evidence for COPD from 1990 to 2019. This study examined the economic burden of COPD through a systematic review of studies from 1990 to 2019. A search was done in online databases, including Web of Science, PubMed/Medline, Scopus, and the Cochrane Library. After screening 12,734 studies, 43 articles that met the inclusion criteria were identified. General study information and data on direct, indirect, and intangible costs were extracted and converted to 2018 international dollars (Int$). Findings revealed that the total direct costs ranged from Int$ 52.08 (India) to Int$ 13,776.33 (Canada) across 16 studies, with drug costs rannging from Int$ 70.07 (Vietnam) to Int$ 8,706.9 (China) in 11 studies. Eight studies explored indirect costs, while one highlighted caregivers' direct costs at approximately Int$ 1,207.8 (Greece). This study underscores the limited research on COPD caregivers' economic burdens, particularly in developing countries, emphasizing the importance of increased research support, particularly in high-resource settings. This study provides information about the demographics and economic burden of COPD from 1990 to 2019. More strategies to reduce the frequency of hospital admissions and acute care services should be implemented to improve the quality of COPD patients' lives and reduce the disease's rising economic burden.

Moutan Root Bark가 항산화활성과 LDL 산화 억제 및 항철소판 응접에 미치는 영향 (Screening of Antioxidative, Anti-thrombotic and Anti-atherosclerotic Effects of Moutan Root Bark Extracts)

  • 반창규;이민자;이혜숙;정현정;김혁;김재은;박선동;박원환
    • 동의생리병리학회지
    • /
    • 제23권1호
    • /
    • pp.135-143
    • /
    • 2009
  • There is currently increased interest in the identification of antioxidant compounds that are pharmacologically potent and have low or no side effects. Plants produce significant amounts of antioxidants to prevent the oxidative stress caused by photons and oxygen, therefore they represent a potential source of new compounds with antioxidant activity. Moutan Root Sark (MRS) has been frequently used as analgesic. antispasmodic, anti-inflammatory and remedies for female diseases. In this study. the antioxidant activity of extract from MRS was studied in vitro methods by measuring the antioxidant activity by TEAC, measuring the scavenging effects on reactive oxygen species (ROS) [superoxide anion, hydroxyl radical] and on reactive nitrogen species (RNS) [nitric oxide and peroxynitrite] as well as measuring the inhibitory effect on $Cu^{2+}$ induced human LDL oxidation and the inhibitory effect on collagen induced platelet aggregation. The MRS extracts were found to have a potent scavenging activity, as well as an inhibitory effect on LDL oxidation and on platelet aggregation. In conclusion, the MRS extracts have anti-oxidative and anti-atherosclerotic effects in vitro system, which can be used for developing pharmaceutical drug against oxidative stress and atherosclerosis.

Allele Frequencies of the Single Nucleotide Polymorphisms Related to the Body Burden of Heavy Metals in the Korean Population and Their Ethnic Differences

  • Eom, Sang-Yong;Lim, Ji-Ae;Kim, Yong-Dae;Choi, Byung-Sun;Hwang, Myung Sil;Park, Jung-Duck;Kim, Heon;Kwon, Ho-Jang
    • Toxicological Research
    • /
    • 제32권3호
    • /
    • pp.195-205
    • /
    • 2016
  • This study was performed to select single nucleotide polymorphisms (SNPs) related to the body burden of heavy metals in Koreans, to provide Korean allele frequencies of selected SNPs, and to assess the difference in allele frequencies with other ethnicities. The candidate-gene approach method and genome-wide association screening were used to select SNPs related to the body burden of heavy metals. Genotyping analysis of the final 192 SNPs selected was performed on 1,483 subjects using the VeraCode Goldengate assay. Allele frequencies differences and genetic differentiations between the Korean population and Chinese (CHB), Japanese (JPT), Caucasian (CEU), and African (YIR) populations were tested by Fisher's exact test and fixation index ($F_{ST}$), respectively. The Korean population was genetically similar to the CHB and JPT populations ($F_{ST}$ < 0.05, for all SNPs in both populations). However, a significant difference in the allele frequencies between the Korean and CEU and YIR populations were observed in 99 SNPs (60.7%) and 120 SNPs (73.6%), respectively. Ten (6.1%) and 26 (16.0%) SNPs had genetic differentiation ($F_{ST}$ > 0.05) among the Korean-CEU and Korean-YIR comparisons, respectively. The SNP with the largest $F_{ST}$ value between the Korean and African populations was cystathionine-${\beta}$-synthase rs234709 ($F_{ST}$: KOR-YIR, 0.309; KOR-CEU, 0.064). Our study suggests that interethnic differences exist in SNPs associated with heavy metals of Koreans, and it should be considered in future studies that address ethnic differences in heavy-metal concentrations in the body and genetic susceptibility to the body burden of heavy metals.

Thelephoric acid의 CYP2J2 효소 활성 저해제 평가 (Inhibitory Potential of Thelephoric Acid on CYP2J2 Activities in Human Liver Microsomes)

  • 오철학;이보람;송경식;류광현
    • 생명과학회지
    • /
    • 제23권9호
    • /
    • pp.1126-1132
    • /
    • 2013
  • CYP2J2 효소는 간외의 조직에 존재 하는 효소로써, 주로 심혈관계에 발현되어 있다. CYP2J2는 내인성 대사체 및 여러 치료 약물들의 대사에 중요한 작용을 하고 있다. 또한 CYP2J2는 인체의 종양조직이나 종양 세포주에서 과발현되어 있어, 종양 치료를 위한 새로운 표적이 되고 있다. 본 연구에서는 천연물 10종을 대상으로 시토크롬 2J2 동효소에 저해능을 가지는 화합물을 발굴하고자 하였다. 10종의 천연물 중 thelephoric acid는 CYP2J2에 의해 매개되는 에바스틴($IC_{50}=5.32{\mu}M$), 아스테미졸($IC_{50}3.23{\mu}M$) 및 터페나딘($IC_{50}=3.27{\mu}M$) 대사를 강력하게 저해하였다. 향후, 이 약물을 대상으로 한 항암 활성 평가가 필요할 것으로 판단된다.

주의력결핍 과잉행동장애 한국형 치료 권고안 개정안(II) - 진단 및 평가 - (The Revised Korean Practice Parameter for the Treatment of Attention-Deficit Hyperactivity Disorder (II) - Diagnosis and Assessment -)

  • 이문수;박수빈;김경미;김현진;박상원;김윤신;이영식;권용실;신동원
    • Journal of the Korean Academy of Child and Adolescent Psychiatry
    • /
    • 제28권2호
    • /
    • pp.58-69
    • /
    • 2017
  • Attention-deficit hyperactivity disorder (ADHD) is a highly prevalent, impairing, and comorbid disorder that persists into adulthood. ADHD should be diagnosed in the same manner as other common adult mental health disorders. The three most important components in the comprehensive evaluation of patients with ADHD are the clinical interview, medical examination, and completion and scoring of behavior rating scales. The diagnostic evaluation of ADHD should include questions about the symptoms, family history, prior evaluation and treatment of ADHD, as well as other problems including alcohol and drug use. Screening interviews or rating scales, as well as interviews, should be used. When it is feasible, clinicians may wish to supplement these components of the evaluation with the objective assessments of the ADHD symptoms, such as through psychological tests. These tests are not essential to reaching a diagnosis, however, or to treatment planning, but may yield further information about the presence and severity of cognitive impairments that could be associated with some cases of ADHD. As comorbidity is the rule rather than the exception, clinicians should carefully screen for comorbid disorders as part of a comprehensive assessment of ADHD. To receive a diagnosis of ADHD, the person must be experiencing significant distress or impairment in his or her daily functioning, and must not meet the criteria for other mental disorders which might better account for the observed symptoms, such as mental retardation, autism or other pervasive developmental disorders, mood disorders and anxiety disorders. This report aims to suggest practice guidelines for the assessment and diagnosis of children, adolescents and adults with ADHD in Korea.

Lonicera Flower의 항산화활성과 LDL 산화 억제효과 및 혈전용해능에 관한 연구 (Screening of Anti-atherosclerotic Effect of Lonicera Flower by Antioxidative and Anti-thrombotic Mechanism)

  • 주신탁;이민자;이혜숙;정현정;김혁;김재은;박선동;박원환
    • 동의생리병리학회지
    • /
    • 제22권6호
    • /
    • pp.1509-1517
    • /
    • 2008
  • The flowers and buds of Lonicera Flower (LF), are used in Korean herbal medicine for latent-heat-clearing, antipyretic, detoxicant and anti-inflammatory ailments. This plant is used worldwide for the treatment of many types of inflammatory disease including respiratory infections, diabetes mellitus, rheumatoid arthritis and play an important role in immune reaction. These pharmaceutical effects of LF looks like to be related to its antioxidant capacity and phytochemicals containing in LF. In this study, the antioxidant activity of extract from LF was studied in vitro methods by measuring the antioxidant activity by TEAC, measuring the scavenging effects on reactive oxygen species (ROS) [superoxide anion, hydroxyl radical] and on reactive nitrogen species (RNS) [nitric oxide and peroxynitrite] as well as measuring the inhibitory effect on $Cu^{2+}$ induced human LDL oxidation and the inhibitory effect on collagen induced platelet aggregation. The LF extracts were found to have a potent scavenging activity, as well as an inhibitory effect on LDL oxidation and on platelet aggregation. In conclusion, the LF extracts have anti-oxidative and anti-atherosclerotic effects in vitro system, which can be used for developing pharmaceutical drug against oxidative stress and atherosclerosis.

자생식물 열수추출액의 항균효능 검색 (Screening of Antibacterial Activity from Hot Water Extracts of Indigenous Plants)

  • 민상기;박연경;박지연;진성현;김규원
    • 생명과학회지
    • /
    • 제14권6호
    • /
    • pp.951-962
    • /
    • 2004
  • 병원성세균에 대한 자생식물 열수 추출물 141종의 항균효능을 검색하였다. 실험대상 식물은 생체 채집하여 건조 후 열수 추출하여 시료화 하였으며 디스크 확산법으로 항균력을 측정하였고 시험 대상 균주로는 그람양성균 7주 및 그람음성균 12주를 사용하였다. 그 결과 그람양성군 1주 이상에 항균효능을 보이는 식물은 55종이었으며 특히 달맞이꽃(꽃), 석류(과피), 굴참나무(도토리), 사방소리 나무(미성숙과), 물오리나무(미성숙과), 칡(꽃), 이질풀(지상부), 배롱나무(꽃)은 6주 이상에서 광범위 항균 스펙트럼를 보였다. 그람음성균 1주 이상에 항균효능을 보이는 식물은 45종이었으며 달맞이 꽃(꽃), 석류(과피), 굴참나무(도토리), 오미자(성숙과), 사방오리나무(미성숙과), 물오리나무(미성숙과), 목련(미성숙과)은 8주 이상에서 광범위 항균스펙트럼을 보였다. 본 연구결과 식용 가능하며 항균효능을 보인 달맞이꽃 (꽃), 석류(과피, 꽃), 굴참나무(도토리), 오미자(성숙과)의 열수 조추출물은 식품 보존제 및 가축 식이사료 등에 첨가하여 병원균 감염예방 등의 항균효과를 기대할 수 있을 것으로 사료된다.

면역시스템을 통한 세포수명연장 천연물질 스크린 (Screening of Natural Product Libraries for the Extension of Cell Life-span through Immune System)

  • 유보경;권기상;고영화;김홍근;이석현;박관호;최지영;권오유
    • 생명과학회지
    • /
    • 제26권3호
    • /
    • pp.359-363
    • /
    • 2016
  • 한약진흥재단(NIKOM)의 640-천연물 라이브러리를 PC12세포에 10 μg/ml/day로 처리하였다. 면역강화에 관여하는 ERAP1 (Endoplasmic Reticulum AminoPeptidase 1)과 수명연장에 관여하는 FOXO1 (FOXO-family transcription factor) 유전자발현을 RT-PCR로 확인하였다. ERAP1 유전자를 1.5-2배까지 상승시킨 것은 22개, 2배 이상 발현시킨 것은 14개였다. FOXO1 유전자를 1.5-2배까지 상승시킨 것은 총 24개, 2배 이상 발현시킨 것은 4개였다. 동시에 ERAP1과 FOXO1 유전자를 2배 이상 상승시키는 것은 족도리풀(Asiasari radix)에서 분리된 (±)-Car-3-ene-2,5-dione, 두꺼비(Bufonis venenum)에서 분리된 Cinobufagin, 대국(Euphorbiae pekinensis)에서 분리된 Corilagin, 현호색(Corydalis tuber)에서 분리된 Corydaline 4종이다. 이들 4종의 천연물은 초파리를 이용한 개체의 수명연장실험에 사용될 것이다.

홍삼약침액(紅蔘藥鍼液)의 DNA와 단백질 발현(發顯)에 미치는 영향(影響) (DNA and Proteomic Analysis of Ginseng Radix Rubra Herbal-acupuncture Solution(GRR-HAS) on Gene Expression in HepG2 Carcinomar Cells)

  • 원은주;이봉효;임성철;정태영;서정철;이경민
    • Journal of Acupuncture Research
    • /
    • 제23권3호
    • /
    • pp.177-190
    • /
    • 2006
  • Objectives : It has long been known about the anticancer effect of GRR-HAS, however, it has not been systemically determined the differentially regulated genes by GRR-HAS in cancer cells. The purpose of this study is to screen the GRR-HAS mediated differentially expressed genes in cancer cells such as HepG2 hepatoma cell lines. Oligonucleotide microarray and proteomic approaches were employed to screen the differential expression genes. Methods : GRR~HAS was prepared by boiling and stored at $-70^{\circ}C$ until use. Cells were treated with various concentrations of GRR-HAS (0.1, 0.5, 1.5, 10, $20mg/m{\ell}$) for 24 h. Cell toxicity was tested by MTT assay. To screen the differentially expressed genes in cancer cells, cells were treated with $1.5mg/m{\ell}$ of GRR-HAS. For oligonucleotide microarray assay, total RNA was used for gene expression analysis using oligonucleotide genechip (Human genome Ul33 Plus 2.0., Affimatrix Co.). For proteomic analysis, total protein was analyzed by 2D gel electrophoresis and Q-TOF mass spectrometer. Results : It has no cytotoxic effects on both HepG2 cells in all concentrations(0.1, 0.5, 1.5, 10,$20mg/m{\ell}$). In oligonucleotide microarray assay, the number of more than twofold differentially regulated known genes was 320 with 6 up-regulated and 314 down-regulated genes in HepG2 cells. In proteomic analysis, three spots were identified by 2D-gel electrophoresis and Q-TOF analysis. One down -regulated protein was protein disulfide isomerase and up-regulated proteins were fatty acid binding protein 1 and 14-3-3 gan1lTIa protein by $1.5mg/m{\ell}$ of CRR-HAS. Discussion : This study showed the comprehensive gene expression analysis using oligonucleotide microarray for the screening of GRR-HAS mediated differentially regulated genes. These results will provide a better application of GRR-HAS in cancer field and drug target development.

  • PDF

생식생물학에세 프로테오믹스의 응용 (Potential Importance of Proteomics in Research of Reproductive Biology)

  • 김호승;윤용달
    • 한국발생생물학회지:발생과생식
    • /
    • 제8권1호
    • /
    • pp.1-9
    • /
    • 2004
  • 프로테오믹스(proteomics, 단백질체학이라고도 함)의 잠재적 중요성은 간질환, 심장질환, 몇몇 종류의 암 등의 의학, 생식 독성, 발생 독성, 생체 독성 연구 분야에서도 명백하게 제시되었다. 그러나 단백질을 대상으로 연구하여 유전자 기능을 연구하는 프로테오믹스 연구를 각각의 분야에 접목시키려는 노력은 아직까지 빈약하다. 프로테오믹스는 기능을 갖는 단백질들의 발현을 종합적이고 정량적으로 측정하는 가장 직접적인 수단이고, 질병, 약물투여, 쇼크, 내분비계 장애물질 등 생물학적인 동요(perturbation)에 의하여 변하는 단백질들의 발현 양상 변화를 정확하게 관찰할 수 있게 한다. 그리고 생체내 유전자 발현의 궁극적인 양상을 규명할 수 있으며, 또한 유전자, 단백질 및 질병간의 연결고리를 제공한다. 기존의 biomarker는 다른 질병 표지자와 연관성이 높아 직접적인 biomaker와 정확한 연관을 판정하기 어렵다. 따라서 대량 발굴 탐색(high-throughput screening)이 가능한 2차원 전기 영동 분석과 MALDI-TOF또는 protein chip array와 SELDI-TOF에 의한 단백질 분자 구조 분석 기술 및 이들을 지원하는 생물정보학(bioinformatics)의 발전을 이용하여, 생식학 연구에 이용할 수 있는 표적 단백질 발굴 및 정성 정량적 연구에 적절한 이용이 가능할 것이다. 이러한 연구는 생식과정 중 배아 발생 및 조직 기관 발생 중 유전자 발현의 변화, 내분비계 장애물질 등 호르몬 및 독성 물질의 작용 기전, ecotoxicogenomics지표 marker의 변동 분석, 중간대사물질체학(metabolomics)에의 이용 등등의 연구에 필수적인 방법으로 발전할 것이다.

  • PDF